Gil Z, Beni-Adani L, Siomin V, Nagar H, Dvir R, Constantini S
Division of Pediatric Neurosurgery, Dana Children's Hospital, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Israel.
Childs Nerv Syst. 2001 Jun;17(7):395-8. doi: 10.1007/s003810100460.
Optic pathway gliomas in children can involve the optic nerve, chiasm, and hypothalamus. This uncommon, slowly growing tumor can cause hydrocephalus, which usually requires placement of a ventriculoperitoneal (VP) shunt. Symptomatic ascites may occasionally develop as a complication of the VP shunt procedure. The purpose of this study was to assess the risk factors associated with CSF ascites in children with optic pathway gliomas.
Twenty-two children (ages 4 months to 20 years) with chiasmatic-hypothalamic optic gliomas participated in this study. Four children were diagnosed with a chiasmatic glioma, 7 with a hypothalamic glioma, and 11 with a glioma involving both the optic chiasm and hypothalamus. Twelve children (55%) developed hydrocephalus and required VP shunt placement. Of the 12 shunted children, 4 (33%) developed CSF ascites. The incidence of ascites was not associated with infection, tumor metastasis, or multiple shunt revisions. There was no correlation with the size of the tumor. All 4 children with ascites had tumor involving the optic chiasm or optic nerve. None of the 5 children with pure hypothalamic glioma who underwent VP shunt placement have developed ascites. Among the 7 children suffering from chiasmatic or optic nerve gliomas who developed hydrocephalus, the risk of developing ascites as a complication of VP shunt placement was 57% (4/7). Ventriculoatrial (VA) shunt was the treatment of choice for children with VP shunt-induced ascites. After placement of a VA shunt the ascites subsided. The children did not develop further complications.
We conclude that glioma involving the optic chiasm or nerve is associated with a high risk of developing ascites following VP shunt placement. VA shunt may be the treatment of choice for children with chiasmatic or optic nerve gliomas who require a CSF diversion procedure.
儿童视路胶质瘤可累及视神经、视交叉和下丘脑。这种不常见的、生长缓慢的肿瘤可导致脑积水,通常需要置入脑室腹腔(VP)分流管。症状性腹水偶尔可作为VP分流术的并发症出现。本研究的目的是评估与视路胶质瘤患儿脑脊液性腹水相关的危险因素。
22例患有视交叉 - 下丘脑视神经胶质瘤的儿童(年龄4个月至20岁)参与了本研究。4例儿童被诊断为视交叉胶质瘤,7例为下丘脑胶质瘤,11例为累及视交叉和下丘脑的胶质瘤。12例儿童(55%)发生脑积水并需要置入VP分流管。在这12例接受分流的儿童中,4例(33%)出现了脑脊液性腹水。腹水的发生率与感染、肿瘤转移或多次分流管修订无关。与肿瘤大小也无相关性。所有4例有腹水的儿童肿瘤均累及视交叉或视神经。5例接受VP分流术的单纯下丘脑胶质瘤患儿均未出现腹水。在7例发生脑积水的视交叉或视神经胶质瘤患儿中,作为VP分流术并发症发生腹水的风险为57%(4/7)。脑室心房(VA)分流术是VP分流术引起腹水患儿的首选治疗方法。置入VA分流管后腹水消退。患儿未出现进一步并发症。
我们得出结论,累及视交叉或神经的胶质瘤与VP分流术后发生腹水的高风险相关。对于需要脑脊液分流手术的视交叉或视神经胶质瘤患儿,VA分流术可能是首选治疗方法。